Scott Gazelle, MD, MPH, PhD

Director, Independent

G. Scott Gazelle, is Professor of Radiology at Harvard Medical School and Professor in the Department of Health Policy and Management at the Harvard School of Public Health. He serves as Director Emeritus of the MGH Institute for Technology Assessment and Director of the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training. Dr. Gazelle is nationally and internationally known for his leadership role in the development and evaluation of radiofrequency tumor ablation, and more generally for his research evaluating the benefits, costs, and appropriate use of new medical technologies. He holds degrees from Dartmouth College, Case Western and Harvard University, and has authored more than 250 scientific articles, published 3 textbooks and presented numerous papers, lectures, and workshops nationally and internationally.

The NvisionVLE Imaging System is indicated for use as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization and may be used to mark areas of tissue.

The safety and effectiveness of this device for diagnostic analysis (i.e. differentiating normal versus specific abnormalities) in any tissue microstructure or specific disease has not been evaluated.